J Gynecol Oncol.  2015 Apr;26(2):83-86. 10.3802/jgo.2015.26.2.83.

Ovarian cancer risk reduction through opportunistic salpingectomy

• Kwon JS

• KMID: 2160789
• DOI: http://doi.org/10.3802/jgo.2015.26.2.83

Abstract

No abstract available.

MeSH Terms

Cost-Benefit Analysis
*Elective Surgical Procedures/economics/utilization
Fallopian Tubes/surgery
Female
Humans
Hysterectomy/economics/methods/utilization
Incidence
Ovarian Neoplasms/economics/epidemiology/*prevention & control
*Risk Reduction Behavior
Salpingectomy/economics/*utilization
Sterilization, Tubal/economics/utilization

Reference

1. Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol. 2007; 31:161–169.

2. Piek JM, van Diest PJ, Zweemer RP, Jansen JW, Poort-Keesom RJ, Menko FH, et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol. 2001; 195:451–456.

3. Przybycin CG, Kurman RJ, Ronnett BM, Shih Ie M, Vang R. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol. 2010; 34:1407–1416.

4. BC's Ovarian Cancer Research Team. Advocating Fallopian Tube removal at the time of hysterectomy to prevent ovarian cancer [Internet]. Vancouver, BC: OVCARE;c2013. cited 2015 Mar 30. Available from: http://www.ovcare.ca/prevention/for_health_professionals.

5. Parker WH, Feskanich D, Broder MS, Chang E, Shoupe D, Farquhar CM, et al. Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study. Obstet Gynecol. 2013; 121:709–716.

6. Herzog TJ, Dinkelspiel HE. Fallopian tube removal: "stic-ing" it to ovarian cancer: what is the utility of prophylactic tubal removal? Curr Oncol. 2013; 20:148–151.

7. Narod SA. Salpingectomy to prevent ovarian cancer: a countercurrents series. Curr Oncol. 2013; 20:145–147.

8. McAlpine JN, Hanley GE, Woo MM, Tone AA, Rozenberg N, Swenerton KD, et al. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention. Am J Obstet Gynecol. 2014; 210:471.e1–471.e11.

9. Minig L, Chuang L, Patrono MG, Cardenas-Rebollo JM, Garcia-Donas J. Surgical outcomes and complications of prophylactic salpingectomy at the time of benign hysterectomy in premenopausal women. J Minim Invasive Gynecol. 2015; 02. 23. [Epub]. http://dx.doi.org/10.1016/j.jmig.2015.02.013.

10. Morelli M, Venturella R, Mocciaro R, Di Cello A, Rania E, Lico D, et al. Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere. Gynecol Oncol. 2013; 129:448–451.

11. Dubuisson JB, Morice P, Chapron C, De Gayffier A, Mouelhi T. Salpingectomy: the laparoscopic surgical choice for ectopic pregnancy. Hum Reprod. 1996; 11:1199–1203.

12. Strandell A, Lindhard A, Waldenstrom U, Thorburn J, Janson PO, Hamberger L. Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Hum Reprod. 1999; 14:2762–2769.

13. Bijen CB, Vermeulen KM, Mourits MJ, de Bock GH. Costs and effects of abdominal versus laparoscopic hysterectomy: systematic review of controlled trials. PLoS One. 2009; 4:e7340.

14. Bhiwandiwala PP, Mumford SD, Feldblum PJ. A comparison of different laparoscopic sterilization occlusion techniques in 24,439 procedures. Am J Obstet Gynecol. 1982; 144:319–331.

15. Findley AD, Siedhoff MT, Hobbs KA, Steege JF, Carey ET, McCall CA, et al. Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial. Fertil Steril. 2013; 100:1704–1708.

16. Lin YJ, Ou YC, Huang FJ, Lin PY, Kung FT, Lan KC. Ovarian response to gonadotropins in patients with tubal factor infertility: salpingectomy versus nonsalpingectomy. J Minim Invasive Gynecol. 2013; 20:637–641.

17. Ni L, Sadiq S, Mao Y, Cui Y, Wang W, Liu J. Influence of various tubal surgeries to serum antimullerian hormone level and outcome of the subsequent IVF-ET treatment. Gynecol Endocrinol. 2013; 29:345–349.

18. Ye XP, Yang YZ, Sun XX. A retrospective analysis of the effect of salpingectomy on serum antiMullerian hormone level and ovarian reserve. Am J Obstet Gynecol. 2015; 212:53.e1–53.e10.

19. Vorwergk J, Radosa MP, Nicolaus K, Baus N, Jimenez Cruz J, Rengsberger M, et al. Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate. J Cancer Res Clin Oncol. 2014; 140:859–865.

20. Repasy I, Lendvai V, Koppan A, Bodis J, Koppan M. Effect of the removal of the Fallopian tube during hysterectomy on ovarian survival: the orphan ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2009; 144:64–67.

21. Morse AN, Schroeder CB, Magrina JF, Webb MJ, Wollan PC, Yawn BP. The risk of hydrosalpinx formation and adnexectomy following tubal ligation and subsequent hysterectomy: a historical cohort study. Am J Obstet Gynecol. 2006; 194:1273–1276.

22. Ghezzi F, Cromi A, Siesto G, Bergamini V, Zefiro F, Bolis P. Infectious morbidity after total laparoscopic hysterectomy: does concomitant salpingectomy make a difference? BJOG. 2009; 116:589–593.

23. Moorman PG, Myers ER, Schildkraut JM, Iversen ES, Wang F, Warren N. Effect of hysterectomy with ovarian preservation on ovarian function. Obstet Gynecol. 2011; 118:1271–1279.

24. Farquhar CM, Sadler L, Harvey SA, Stewart AW. The association of hysterectomy and menopause: a prospective cohort study. BJOG. 2005; 112:956–962.

25. Siddle N, Sarrel P, Whitehead M. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril. 1987; 47:94–100.

26. Kwon JS, McAlpine JN, Hanley GE, Finlayson SJ, Cohen T, Miller DM, et al. Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy. Obstet Gynecol. 2015; 125:338–345.

27. King JT Jr, Tsevat J, Lave JR, Roberts MS. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation. Med Decis Making. 2005; 25:667–677.

28. Brisson M, Van de Velde N, De Wals P, Boily MC. Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection. CMAJ. 2007; 177:464–468.

29. Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009; 10:327–340.

30. Partridge E, Kreimer AR, Greenlee RT, Williams C, Xu JL, Church TR, et al. Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol. 2009; 113:775–782.

31. Havrilesky LJ, Moorman PG, Lowery WJ, Gierisch JM, Coeytaux RR, Urrutia RP, et al. Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis. Obstet Gynecol. 2013; 122:139–147.

32. Camanni M, Mistrangelo E, Febo G, Ferrero B, Deltetto F. Prophylactic bilateral oophorectomy during vaginal hysterectomy for benign pathology. Arch Gynecol Obstet. 2009; 280:87–90.

33. Candiani M, Izzo S, Bulfoni A, Riparini J, Ronzoni S, Marconi A. Laparoscopic vs vaginal hysterectomy for benign pathology. Am J Obstet Gynecol. 2009; 200:368.e1. 368.e7.

34. Cho HY, Kang SW, Kim HB, Park SH, Park ST. Prophylactic adnexectomy along with vaginal hysterectomy for benign pathology. Arch Gynecol Obstet. 2012; 286:1221–1225.

35. Karp DR, Mukati M, Smith AL, Suciu G, Aguilar VC, Davila GW. Predictors of successful salpingo-oophorectomy at the time of vaginal hysterectomy. J Minim Invasive Gynecol. 2012; 19:58–62.

36. Cruikshank SH, Kovac SR. Randomized comparison of three surgical methods used at the time of vaginal hysterectomy to prevent posterior enterocele. Am J Obstet Gynecol. 1999; 180:859–865.

37. Shepherd JP, Zyczynski HM. Removal of adnexa at the time of vaginal hysterectomy. Clin Obstet Gynecol. 2010; 53:17–25.

38. Committee on Gynecologic Practice. Committee opinion no. 620: salpingectomy for ovarian cancer prevention. Obstet Gynecol. 2015; 125:279–281.